Oragenics Inc (OGEN)
0.3349
-0.04
(-10.69%)
USD |
NYAM |
Jan 08, 12:11
Oragenics SG&A Expense (Quarterly): 1.558M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
Microbot Medical Inc | 1.24M |
Alaunos Therapeutics Inc | 1.007M |
SELLAS Life Sciences Group Inc | 2.967M |
Galectin Therapeutics Inc | 1.471M |
Anavex Life Sciences Corp | 2.781M |